Alaska Permanent Fund’s CVS Health CVS Stock Holding History

Alaska Permanent Fund’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-39,540	Closed	-$2.64M	–	116
2025 Q1	$2.64M	Hold	39,540	–	–	0.04%	214
2024 Q4	$1.77M	Hold	39,540	–	–	0.03%	309
2024 Q3	$2.49M	Hold	39,540	–	–	0.04%	267
2024 Q2	$2.39M	Buy	39,540 +5,262	+15%	+$329K	0.04%	282
2024 Q1	$2.73M	Buy	34,278 +1,329	+4%	+$102K	0.04%	219
2023 Q4	$2.6M	Buy	32,949 +449	+1%	+$32K	0.04%	220
2023 Q3	$2.27M	Hold	32,500	–	–	0.04%	229
2023 Q2	$2.25M	Buy	+32,500	New	+$2.31M	0.04%	292
2022 Q2	–	Sell	-29,300	Closed	-$2.96M	–	416
2022 Q1	$2.96M	Hold	29,300	–	–	0.05%	62
2021 Q4	$3.12M	Hold	29,300	–	–	0.06%	45
2021 Q3	$2.49M	Hold	29,300	–	–	0.05%	99
2021 Q2	$2.44M	Sell	29,300 -10,100	-26%	-$827K	0.04%	111
2021 Q1	$2.96M	Hold	39,400	–	–	0.05%	150
2020 Q4	$2.69M	Hold	39,400	–	–	0.05%	146
2020 Q3	$2.3M	Buy	39,400 +24,510	+165%	+$1.53M	0.04%	59
2020 Q2	$967K	Hold	14,890	–	–	0.02%	64
2020 Q1	$883K	Buy	+14,890	New	+$994K	0.02%	49

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alaska Permanent Fund's CVS Position: Q2 2025 in Review

Alaska Permanent Fund sold out of CVS Health (CVS) in Q2 2025, closing a stake of 39,540 shares — an estimated $2.64M sold.

Alaska Permanent Fund first reported a position in CVS in Q1 2020 and held it in 17 quarters. The position peaked at $3.12M in Q4 2021. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Alaska Permanent Fund reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 39,540 CVS Health shares in Q2 2025, an estimated $2.64M.
Alaska Permanent Fund first reported a position in CVS Health in Q1 2020 and held it in 17 quarters.
Alaska Permanent Fund's CVS Health position peaked at $3.12M in Q4 2021.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.